AF
SMED

Amalgamated Financial’s Sharps Compliance Corp SMED Stock Holding History

Amalgamated Financial’s Portfolio SMED Stock Details SMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$18K Buy
+3,024
New +$19K ﹤0.01% 2780

Other funds holding SMED

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Amalgamated Financial's SMED Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Sharps Compliance Corp (SMED) in Q1 2022: 3,024 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #2780 among its holdings.

80 funds tracked by Wall St. Rank hold SMED as of Q1 2022.

  • Amalgamated Financial held 3,024 shares of Sharps Compliance Corp worth $18K as of Q1 2022.
  • Sharps Compliance Corp was a new Amalgamated Financial position in Q1 2022.
  • Sharps Compliance Corp made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2780 holding.
  • 80 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.